Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.390
+0.010 (0.72%)
At close: Mar 9, 2026, 4:00 PM EDT
1.380
-0.010 (-0.72%)
After-hours: Mar 9, 2026, 4:53 PM EDT
PACB Revenue
In the year 2025, Pacific Biosciences of California had annual revenue of $160.01M with 3.89% growth. Pacific Biosciences of California had revenue of $44.65M in the quarter ending December 31, 2025, with 13.82% growth.
Revenue (ttm)
$160.01M
Revenue Growth
+3.89%
P/S Ratio
2.50
Revenue / Employee
$329,907
Employees
485
Market Cap
419.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 160.01M | 5.99M | 3.89% |
| Dec 31, 2024 | 154.01M | -46.51M | -23.19% |
| Dec 31, 2023 | 200.52M | 72.22M | 56.29% |
| Dec 31, 2022 | 128.30M | -2.21M | -1.69% |
| Dec 31, 2021 | 130.51M | 51.62M | 65.43% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Varex Imaging | 854.40M |
| Orthofix Medical | 822.31M |
| Viemed Healthcare | 270.28M |
| OrthoPediatrics | 236.35M |
| Cerus | 206.13M |
| Beta Bionics | 100.25M |
| NeuroPace | 99.99M |
| Standard BioTools | 85.33M |
PACB News
- 4 days ago - PacBio Announces the Appointment of Chris Gibson to the Board of Directors - GlobeNewsWire
- 13 days ago - PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research - GlobeNewsWire
- 19 days ago - PacBio to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 23 days ago - Pacific Biosciences of California, Inc. (PACB) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - PacBio Completes Sale of Short-Read Sequencing Assets - GlobeNewsWire
- 5 weeks ago - PacBio: The Consumables Flywheel Is Turning. The Chart Wants Confirmation - Seeking Alpha
- 5 weeks ago - PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - GlobeNewsWire
- 2 months ago - Pacific Biosciences of California, Inc. (PACB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha